Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)

Barbara Schwartzberg; John Lewin; Osama Abdelatif; Jacqueline Bernard; Hanadi Bu-Ali; Simon Cawthorn; Margaret Chen-Seetoo; Sheldon Feldman; Sasirekha Govindarajulu; Lyn Jones; Arne Juette; Sanjay Kavia; Robert Maganini; Simon Pain; Mike Shere; Craig Shriver; Simon Smith; Alexandra Valencia; Eric Whitacre; Roger Whitney

doi:10.1245/s10434-018-6861-3

Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)

Barbara Schwartzberg^*
, John Lewin
, Osama Abdelatif
, Jacqueline Bernard
, Hanadi Bu-Ali
, Simon Cawthorn
, Margaret Chen-Seetoo
, Sheldon Feldman
, Sasirekha Govindarajulu
, Lyn Jones
, Arne Juette
, Sanjay Kavia
, Robert Maganini
, Simon Pain
, Mike Shere
, Craig Shriver
, Simon Smith
, Alexandra Valencia
, Eric Whitacre
, Roger Whitney

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

The article “Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations”, written by Barbara Schwartzberg et al., was originally published electronically on the publisher’s internet portal (currently SpringerLink) on July 9, 2018, without open access.

Original language	English
Pages (from-to)	998
Number of pages	1
Journal	Annals of Surgical Oncology
Volume	25
DOIs	https://doi.org/10.1245/s10434-018-6861-3
State	Published - 17 Dec 2018

Access to Document

10.1245/s10434-018-6861-3

Fingerprint

Dive into the research topics of 'Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)'. Together they form a unique fingerprint.

Cite this

Schwartzberg, B., Lewin, J., Abdelatif, O., Bernard, J., Bu-Ali, H., Cawthorn, S., Chen-Seetoo, M., Feldman, S., Govindarajulu, S., Jones, L., Juette, A., Kavia, S., Maganini, R., Pain, S., Shere, M., Shriver, C., Smith, S., Valencia, A., Whitacre, E., & Whitney, R. (2018). Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2). Annals of Surgical Oncology, 25, 998. https://doi.org/10.1245/s10434-018-6861-3

Schwartzberg, Barbara ; Lewin, John ; Abdelatif, Osama et al. / Correction to : Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2). In: Annals of Surgical Oncology. 2018 ; Vol. 25. pp. 998.

@article{abb88452de4d49a1b9821b5c50115553,

title = "Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)",

abstract = "The article “Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations”, written by Barbara Schwartzberg et al., was originally published electronically on the publisher{\textquoteright}s internet portal (currently SpringerLink) on July 9, 2018, without open access.",

author = "Barbara Schwartzberg and John Lewin and Osama Abdelatif and Jacqueline Bernard and Hanadi Bu-Ali and Simon Cawthorn and Margaret Chen-Seetoo and Sheldon Feldman and Sasirekha Govindarajulu and Lyn Jones and Arne Juette and Sanjay Kavia and Robert Maganini and Simon Pain and Mike Shere and Craig Shriver and Simon Smith and Alexandra Valencia and Eric Whitacre and Roger Whitney",

note = "Publisher Copyright: {\textcopyright} 2018, The Author(s).",

year = "2018",

month = dec,

day = "17",

doi = "10.1245/s10434-018-6861-3",

language = "English",

volume = "25",

pages = "998",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Schwartzberg, B, Lewin, J, Abdelatif, O, Bernard, J, Bu-Ali, H, Cawthorn, S, Chen-Seetoo, M, Feldman, S, Govindarajulu, S, Jones, L, Juette, A, Kavia, S, Maganini, R, Pain, S, Shere, M, Shriver, C, Smith, S, Valencia, A, Whitacre, E & Whitney, R 2018, 'Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)', Annals of Surgical Oncology, vol. 25, pp. 998. https://doi.org/10.1245/s10434-018-6861-3

Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2). / Schwartzberg, Barbara; Lewin, John; Abdelatif, Osama et al.
In: Annals of Surgical Oncology, Vol. 25, 17.12.2018, p. 998.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2)

AU - Schwartzberg, Barbara

AU - Lewin, John

AU - Abdelatif, Osama

AU - Bernard, Jacqueline

AU - Bu-Ali, Hanadi

AU - Cawthorn, Simon

AU - Chen-Seetoo, Margaret

AU - Feldman, Sheldon

AU - Govindarajulu, Sasirekha

AU - Jones, Lyn

AU - Juette, Arne

AU - Kavia, Sanjay

AU - Maganini, Robert

AU - Pain, Simon

AU - Shere, Mike

AU - Shriver, Craig

AU - Smith, Simon

AU - Valencia, Alexandra

AU - Whitacre, Eric

AU - Whitney, Roger

PY - 2018/12/17

Y1 - 2018/12/17

N2 - The article “Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations”, written by Barbara Schwartzberg et al., was originally published electronically on the publisher’s internet portal (currently SpringerLink) on July 9, 2018, without open access.

AB - The article “Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations”, written by Barbara Schwartzberg et al., was originally published electronically on the publisher’s internet portal (currently SpringerLink) on July 9, 2018, without open access.

UR - https://www.scopus.com/pages/publications/85054787990

U2 - 10.1245/s10434-018-6861-3

DO - 10.1245/s10434-018-6861-3

M3 - Comment/debate

C2 - 30298314

AN - SCOPUS:85054787990

SN - 1068-9265

VL - 25

SP - 998

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -

Schwartzberg B, Lewin J, Abdelatif O, Bernard J, Bu-Ali H, Cawthorn S et al. Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (Annals of Surgical Oncology, (2018), 25, 10, (2958-2964), 10.1245/s10434-018-6623-2). Annals of Surgical Oncology. 2018 Dec 17;25:998. doi: 10.1245/s10434-018-6861-3